Carevision bets a phone camera can replace clinic visits for cardiometabolic screening

An AI healthtech platform that turns any smartphone camera into a 60-second cardiometabolic risk scanner for early detection of heart and metabolic disease risk.

That an AI model reading a smartphone camera video can deliver a credible 60-second cardiometabolic risk scan, making screening a mass-market product in MENA and beyond.

Founded in 2024 by Amani Abulaban in Jordan, Carevision set out to make preventive screening accessible to everyone by building infrastructure for wellness at scale - early detection of cardiometabolic risk before conditions escalate.

Carevision was selected for the 11th cohort of the Sanabil Accelerator by 500 Global (April 5 - July 1, 2026), one of eight startups chosen from more than 690 applications, described as an AI platform that transforms any smartphone camera into a 60-second cardiometabolic risk scanner. It presented at Demo Day in Riyadh on July 1, 2026. The company also opened a seed round after participating in the Jordan x 2080 Accelerator's Demo Day in Amman, with 2080 Ventures contributing capital as anchor investor.

Still live and raising: Carevision completed the 500 Global/Sanabil cohort in July 2026, and its seed round remains open with 2080 Ventures as anchor investor.

A smartphone scan removes the biggest barriers to screening: no device to buy, no clinic visit, no lab appointment.

MENA is a good proving ground because clinic access is thin in many areas, so the 60-second scan addresses a felt problem rather than a hypothetical one.

Accelerator sequencing bought Carevision capital access: the 500 Global/Sanabil program opened investor doors, and 2080 Ventures anchored its seed round.

Pick the wedge the market can already hold: by making the phone the diagnostic device, Carevision needed no new hardware or lab infrastructure to reach users in markets with thin clinic access.

As of September 2026, Carevision is a seed-stage company, still raising. It completed the Sanabil Accelerator by 500 Global's 11th cohort in July 2026, then announced an investment from 2080 Ventures, which anchored its open seed round alongside MENA and US co-investors. The company's focus remains the smartphone-based cardiometabolic risk scan, targeting preventive wellness at scale in markets without easy clinic access.